Compare BIRD & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIRD | VNRX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2M | 22.5M |
| IPO Year | 2021 | 2012 |
| Metric | BIRD | VNRX |
|---|---|---|
| Price | $7.24 | $0.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $8.00 | $1.67 |
| AVG Volume (30 Days) | ★ 13.8M | 3.5M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.22 | ★ 38.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $152,466,000.00 | $1,727,384.00 |
| Revenue This Year | N/A | $355.66 |
| Revenue Next Year | $35.12 | $849.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $2.15 | $0.14 |
| 52 Week High | $24.31 | $0.94 |
| Indicator | BIRD | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 31.91 |
| Support Level | $4.24 | N/A |
| Resistance Level | $9.87 | $0.18 |
| Average True Range (ATR) | 2.46 | 0.01 |
| MACD | 0.18 | -0.00 |
| Stochastic Oscillator | 21.83 | 10.34 |
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.